---
title: Computational & In-Silico Drug Discovery CROs in United States
path: /services/computational-drug-discovery/us
companies_count: 11
---

# Computational & In-Silico Drug Discovery CROs in United States

11 published CROs match Computational & In-Silico Drug Discovery in United States.

Locations in this set include United States, China, United Kingdom, India, Japan, and South Korea.

Capabilities that show up most often in this set: Small Molecule, Antibody-Drug Conjugate (ADC), Oligonucleotide, Peptide, and Biologics (Monoclonal Antibodies).

## Matching companies

- [AAPharmaSyn](/companies/aapharmasyn)
  - Medicinal chemistry CRO specializing in custom lipid synthesis, stable isotope labeling, hit-to-lead optimization, and process development for pharmaceutical and biotech clients since 2006.
- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [Beantown Biotech](/companies/beantownbiotech)
  - Boston-based CRO specializing in assay development and biochemical & cellular screening for early-stage drug discovery, from target validation through lead optimization.
- [BioDuro-Sundia](/companies/bioduro-sundia)
  - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.
- [Certara](/companies/certara)
  - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
- [ChemDiv](/companies/chemdiv)
  - ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.
- [ChemPartner](/companies/chempartner)
  - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
- [HitGen Inc.](/companies/hitgen)
  - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Synfini, Inc.](/companies/synfini)
  - Synfini provides AI-driven drug discovery services from target selection through lead optimization, combining cloud-based AI design tools with robotic wet lab automation to accelerate DMTA cycles across diverse chemical modalities and therapeutic indications.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.